ABSTRACT

Diabetes mellitus is a global epidemic associated with numerous complications that affect multiple organ systems. The conventional approaches to managing these complications often have limitations in terms of efficacy and safety. Nanoparticle-based drug delivery systems have emerged as a promising avenue to address diabetes-related complications more effectively. This review explores the recent developments in nanoparticle delivery systems for treating complications such as diabetic retinopathy, neuropathy, nephropathy, and cardiovascular diseases. We discuss the advantages, challenges, and potential future directions of utilizing nanoparticles to improve the therapeutic outcomes of patients with diabetes. Keywords: diabetes complications, nanoparticle delivery systems, diabetic retinopathy, neuropathy, drug delivery, nanomedicine, clinical translation
Publication date: 01/12/2024

https://ijbpas.com/pdf/2024/December/MS_IJBPAS_2024_8547.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.12.8547